Publicaciones en colaboración con investigadores/as de Hospital Universitario Central de Asturias (20)

2026

  1. Lung Diffusing Capacity Improves the Prognostic Validity of the GOLD Spirometric Staging in COPD

    Archivos de Bronconeumologia, Vol. 62, Núm. 1, pp. 20-27

2025

  1. Sleep-disordered Breathing in Patients with Chronic Obstructive Pulmonary Disease: Prevalence and Outcomes

    Annals of the American Thoracic Society, Vol. 22, Núm. 8, pp. 1227-1235

2023

  1. Metallomic Signatures of Lung Cancer and Chronic Obstructive Pulmonary Disease

    International Journal of Molecular Sciences, Vol. 24, Núm. 18

2021

  1. COPD Clinical Control: predictors and long-term follow-up of the CHAIN cohort

    Respiratory research, Vol. 22, Núm. 1, pp. 36

  2. Clinical and Prognostic Impact of Low Diffusing Capacity for Carbon Monoxide Values in Patients With Global Initiative for Obstructive Lung Disease I COPD

    Chest, Vol. 160, Núm. 3, pp. 872-878

  3. Natural Course of the Diffusing Capacity of the Lungs for Carbon Monoxide in COPD: Importance of Sex

    Chest, Vol. 160, Núm. 2, pp. 481-490

2020

  1. Phenotypic characterisation of early copd: A prospective case–control study

    ERJ Open Research, Vol. 6, Núm. 4, pp. 1-13

2018

  1. Changes and Clinical Consequences of Smoking Cessation in Patients With COPD: A Prospective Analysis From the CHAIN Cohort

    Chest, Vol. 154, Núm. 2, pp. 274-285

  2. Temporal transitions in COPD severity stages within the GOLD 2017 classification system

    Respiratory Medicine, Vol. 142, pp. 81-85

  3. The importance of symptoms in the longitudinal variability of clusters in COPD patients: A validation study

    Respirology, Vol. 23, Núm. 5, pp. 485-491

2017

  1. A simple algorithm for the identification of clinical COPD phenotypes

    European Respiratory Journal, Vol. 50, Núm. 5

  2. Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD

    The European respiratory journal, Vol. 50, Núm. 5

  3. Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease

    Journal of the American Medical Directors Association, Vol. 18, Núm. 12, pp. 1097.e11-1097.e24

2016

  1. Defining the asthma-COPD overlap syndrome in a COPD Cohort

    Chest, Vol. 149, Núm. 1, pp. 45-52

2015

  1. Differential effect of modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for symptoms evaluation within the new GOLD staging and mortality in COPD

    Chest, Vol. 148, Núm. 1, pp. 159-168

  2. Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: A pooled analysis of individual patient data

    The Lancet Respiratory Medicine, Vol. 3, Núm. 6, pp. 443-450

  3. What pulmonologists think about the asthma–COPD overlap syndrome

    International Journal of COPD, Vol. 10, pp. 1321-1330

2014

  1. Clinical application of the COPD assessment test: Longitudinal data from the COPD history assessment in Spain (CHAIN) Cohort

    Chest, Vol. 146, Núm. 1, pp. 111-122

  2. Erratum: New GOLD classification: Longitudinal data on group assignment [Respir Res. 15, (2014) 3, 10.1186/1465-9921-15-3]

    Respiratory Research

  3. New GOLD classification: Longitudinal data on group assignment

    Respiratory Research, Vol. 15, Núm. 1